Accendra Health (ACH) COO surrenders shares for tax withholding, retains stake

Rhea-AI Filing Summary

Accendra Health executive Perry A. Bernocchi reported a routine tax-related share disposition. On March 20, 2026, he surrendered 20,841 shares of common stock at $2.03 per share to the company to satisfy tax withholding obligations tied to vesting restricted stock. This was not an open-market sale, and he still directly holds 321,821 shares after the transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bernocchi Perry A

(Last) (First) (Middle)

ACCENDRA HEALTH INC.

4435 WATERFRONT DRIVE

(Street)

GLEN ALLEN VIRGINIA 23060

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACCENDRA HEALTH INC/VA/ [ ACH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/20/2026		F		20,841(1)	D	$2.03	321,821	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

	Perry A. Bernocchi, by Rosemarie France POA	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Accendra Health (ACH) report for Perry A. Bernocchi?

Accendra Health executive Perry A. Bernocchi reported surrendering 20,841 common shares to the company. The shares were used to cover tax withholding tied to vesting restricted stock, rather than being sold on the open market.

Was the Accendra Health (ACH) Form 4 transaction an open-market sale?

No, the Form 4 for Accendra Health shows a tax-withholding disposition, not an open-market sale. Shares were surrendered back to the company to pay taxes on vesting restricted stock granted to the executive.

How many Accendra Health (ACH) shares did Perry Bernocchi surrender for taxes?

Perry A. Bernocchi surrendered 20,841 shares of Accendra Health common stock. These shares were delivered to the company at a price of $2.03 per share to satisfy tax withholding obligations arising from restricted stock vesting.

How many Accendra Health (ACH) shares does Perry Bernocchi hold after the Form 4 transaction?

After the tax-withholding disposition, Perry A. Bernocchi directly holds 321,821 Accendra Health common shares. This figure reflects his position following surrender of 20,841 shares to cover tax obligations on vested restricted stock.

What does transaction code "F" mean in the Accendra Health (ACH) Form 4?

Transaction code “F” on the Accendra Health Form 4 indicates shares were used to pay an exercise price or tax liability. Here, it reflects shares surrendered to satisfy tax withholding on restricted stock vesting, not a discretionary market sale.